 ZUG, Switzerland and BOSTON, Dec. 01, 2022 GLOBE NEWSWIRE -- CRISPR Therapeutics Nasdaq: CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in a fireside chat at the 2022 BMO Growth ESG Conference on Wednesday, December 7, 2022, at 1:00 p.m. ET. 